Paradromics is a pioneering company dedicated to developing advanced brain-computer interface (BCI) technologies that address critical unmet medical needs. Their flagship product, the Connexus® BCI, marks a significant leap beyond traditional research-grade BCIs by allowing high-data-rate collection of neural signals for long-term therapeutic applications. This innovative technology enables direct communication between the brain and digital devices, aiming to transform treatment options for various conditions, including sensory and motor deficits, severe depression, and pain management. Paradromics is deeply committed to innovation and collaboration, partnering with scientists and engineers to create cutting-edge software solutions that enhance their clinical applications and broaden the capabilities of their platform, ultimately striving to improve the quality of life for millions of individuals.